The Maryland Racing Commission Sept. 17 adopted uniform medication and drug-testing rules as part of a push in the Mid-Atlantic region.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
Some of racing's most notable owners pledged to race 2-year-olds of 2012 without furosemide and adjunct bleeder medications, TOBA announced July 19.
The West Virginia Racing Commission voted April 13 to ban the use of adjunct bleeder medications on race day and to adopt much stricter penalties for drug violations.
- By Tom LaMarra
Horsemen's groups largely support proposed changes in race-day medication rules but are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
The Delaware Thoroughbred Racing Commission has approved model uniform medication rules as recommended by regulators in the Mid-Atlantic region and hopes to have blood-gas testing for "milkshakes" in place by the time Delaware Park opens April 30 for its 135-day meet.
The Kentucky Equine Drug Research Council set in motion major changes in the state's medication and drug-testing policies when it voted Feb. 4 to recommend adoption of the model rules devised by the national Racing Medication and Testing Consortium.
Regulators in the Mid-Atlantic region, who have been working together for years on uniform medication rules, agreed Jan. 20 to endorse the model medication and drug testing policy devised by the national Racing Medication and Testing Consortium.
The National Horsemen's Benevolent and Protective Association has adopted a position paper on medication and drug-testing that says any changes in policies in each jurisdiction should be enacted only after there is scientific evidence specific therapeutic drugs shouldn't be used in racehorses.
The Racing Medication and Testing Consortium is moving forward with a national policy statement and plans to incorporate.
Industry representatives in West Virginia met by teleconference Oct. 15 to devise emergency rules to govern use of adjunct bleeder medications and to ban the practice of blood-doping.
Most Popular Stories
- TOBA Names Top Owners, Breeders for 2014
- Big Blue Kitten Takes United Nations
- Shaman Ghost Rallies to Take Queen's Plate
- Favorite Tale Upsets Champion Work All Week
- Filly is First Winner for Albertus Maximus
- American Pharoah to Haskell
- Bradester Too Strong in Salvator Mile
- Lady Eli Sparkles in Belmont Oaks
- Grand Bili Upsets Barbados in Carry Back
- Merry Meadow Wins Princess Rooney in Return